Filing Details

Accession Number:
0001209191-13-029241
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2013-05-28 19:42:45
Reporting Period:
2013-05-13
Filing Date:
2013-05-28
Accepted Time:
2013-05-28 19:42:45
Original Submission Date:
2013-05-15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479790 Philippe Prokocimer C/O Trius Therapeutics, Inc.
6310 Nancy Ridge Dr, # 105
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-13 12,000 $7.65 98,022 No 4 S Indirect By The Philippe Prokocimer and Maria Prokocimer Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By The Philippe Prokocimer and Maria Prokocimer Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,429 Direct
Footnotes
  1. The reporting person filed a Form 4 reporting a sale of 12,000 shares of common stock on May 13, 2013 which was cancelled by the broker. As ofMay 13, 2013, the reporting person owned 98,022 shares of common stock indirectly by trust.
  2. Includes 396 and 534 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/18/12 and 11/20/12, respectively.